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Impaired prepulse inhibition and prepulse-elicited reactivity but
intact reflex circuit excitability in unmedicated schizophrenia
patients: a comparison with healthy subjects and medicated
schizophrenia patients
Abstract
Deficient sensorimotor gating as indexed by prepulse inhibition (PPI) of the startle response has been
reported repeatedly in patients suffering from schizophrenia. According to the widely accepted
"protective hypothesis," PPI reflects the protection of ongoing information processing against
interference by other stimuli. Alternatively, it has been proposed that PPI might be regulated by startle
reflex circuit excitability. In the present study, we evaluated these 2 conceptually divergent approaches
underlying the regulation of PPI. To this end, we assessed sensorimotor gating as indexed by PPI, the
reactivity to the prepulse-alone stimulus indexed as prepulse-elicited reactivity (PPER), and acoustic
blink reflex excitability in terms of paired pulse suppression (PPS) within a single recording session in
13 unmedicated and 24 medicated (11 first break) schizophrenia patients in comparison to 43 healthy
control subjects. The results showed that PPI was significantly reduced in unmedicated, but not in
medicated schizophrenia patients. Furthermore, unmedicated patients could be distinguished from the
medicated patients and control subjects in terms of PPER. In contrast to PPI, PPS did not differ between
patients and control subjects. These findings are in line with the "protective hypothesis" of PPI and
indicate that reduced sensorimotor gating in schizophrenia patients might be based on a reduced
perception and/or processing of the prepulse stimulus. The extent to which PPER may or may not be
causally associated with sensorimotor gating in schizophrenia has to be further investigated in human
and animal studies.
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ABSTRACT 
Deficient sensorimotor gating as indexed by prepulse inhibition of the startle response 
(PPI) has been reported repeatedly in patients suffering from schizophrenia. According to the 
widely accepted “protective hypothesis” PPI reflects the protection of on-going information 
processing against interference by other stimuli. Alternatively, it has been proposed that PPI 
might be regulated by startle reflex circuit excitability. In the present study we evaluated these 
two conceptually divergent approaches underlying the regulation of PPI. To this end, we 
assessed sensorimotor gating as indexed by PPI, the reactivity to the prepulse-alone stimulus 
indexed as prepulse elicited reactivity (PPER) and acoustic blink reflex excitability in terms 
of paired pulse suppression (PPS) within a single recording session in unmedicated and 
medicated schizophrenia patients in comparison to healthy control subjects. The results 
showed that PPI was significantly reduced in unmedicated, but not in medicated 
schizophrenia patients. Furthermore, unmedicated patients, exhibiting a deficiency in PPI 
could be distinguished from the medicated patients and control subjects in terms of PPER. In 
contrast to PPI, PPS was not differing between patients and control subjects. These findings 
are in line with the “protective hypothesis” of PPI and indicate that reduced sensorimotor 
gating in schizophrenia patients might be based on a reduced perception and / or processing of 
the prepulse stimulus. The extent to which PPER may or may not be causally associated with 
sensorimotor gating in schizophrenia has to be further investigated in human and animal 
studies. 
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INTRODUCTION 
It has been postulated that impaired cognition and positive symptoms of schizophrenia 
are related to deficient inhibition and / or filtering during early information processing, 
potentially leading to sensory overload, which is thought to be associated with psychotic 
symptom formation (for a review see Braff et al. 2001). Central inhibition or gating can be 
assessed by prepulse inhibition (PPI) of the acoustic startle response. PPI refers to the 
attenuation of the reflexive startle reaction elicited by an intense pulse stimulus when its 
presentation is shortly preceded (30 to 500 ms) by a weak prepulse stimulus (Graham 1975; 
Hoffman and Ison 1980). According to the “protective hypothesis” of Graham (1975, 1980, 
1992), the inhibitory effect of the prepulse stimulus upon subsequent pulse stimulus 
processing reflects the protection of the on-going processing of the antecedent prepulse 
against interference by the succeeding pulse. Deficient sensorimotor gating has been 
described in patients with schizophrenia by many different investigators worldwide (for a 
review see Braff et al. 2001). 
 
On the basis of the theoretical accounts put forward by Graham (1975, 1980, 1992) 
and Braff et al. (1992) enhanced perception of the prepulse stimulus and therefore of its 
processing would be associated with an enhancement of PPI. Indeed, it is widely accepted that 
a more intense prepulse will generate a stronger PPI effect (Blumenthal 1995; Graham and 
Murray 1977a). Moreover, manipulations designed to influence the perception of the prepulse 
stimulus, such as verbal instructions to attend or ignore the prepulse stimulus in human 
subjects, can produce clear effects on the magnitude of PPI. Increased inhibition has been 
observed when subjects were instructed to explicitly attend to the prepulse stimulus (Elden 
and Flaten 2003; Filion and Poje 2003; Hazlett et al. 2003; Heekeren et al. 2004). Similarly, it 
has been suggested that the disrupting effect of the dopamine agonist apomorphine on PPI in 
rats might be based on reduced detectability of weak prepulse stimuli (Davis et al. 1990). 
Furthermore, a positive correlation between prepulse elicited reactivity (PPER) and PPI has 
been found recently in mice (Yee et al. 2004b, 2004a). Therefore, the speculation arises that 
reduced sensorimotor gating in schizophrenia patients could be related to a weakened 
perception of and / or reaction to the prepulse stimulus. 
 
Although it has been generally assumed that a prepulse of a typical intensity used in 
human and animal PPI experiments (8 to 16 dB above background noise) does not per se 
elicit a measurable motor response (Graham 1975; Hoffman and Ison 1980; Ison et al. 1990; 
 
Swerdlow et al. 2002), Blumenthal et al. (1988, 1991) have shown over a decade ago that 
auditory stimuli of an intensity in the range of 50-60 dBA are indeed able to elicit a 
measurable motor response in the absence of a constant background noise. Yet this finding 
cannot be readily generalized to studies in which a background noise, partly masking the 
prepulse stimulus, is applied. Until recently (Csomor et al. 2005, 2006, 2007; Dahmen and 
Corr 2004; Swerdlow et al. 2004, 2006b; Yee et al. 2004b, 2004a), few attempts have been 
made to assess directly the reaction or the processing to the prepulse stimulus per se, as it is 
not uncommon that trials in which only the prepulse stimulus is presented, thus allowing a 
quantification of PPER, are omitted in the testing procedures. However, a number of recent 
studies directly assessing PPER in human and animal experiments, yield divergent results. 
Dahmen & Corr (2004) reported notable PPER that led them to classify it as a startle 
response, and we recently demonstrated that quantification of PPER, although of a magnitude 
much less than that reported by Dahmen & Corr (2004), is reliable and reproducible in a 
series of experiments including healthy human volunteers (Csomor et al. 2005, 2006, 2007) 
and rodents (Yee et al. 2004b, 2004a). In contrast, Swerdlow and coworkers failed to detect 
significant response to prepulse stimuli per se in healthy volunteers (Swerdlow et al. 2004, 
2006b), schizophrenia patients (Swerdlow et al. 2006b) and rodents (Swerdlow et al. 2004). 
 
As an alternative to the “protective hypothesis” of sensorimotor gating, Schicatano et 
al. (2000) suggested that PPI might be more closely governed by reflex excitability. Based on 
their findings in rodents and patients with Parkinson’s disease, the authors proposed that the 
blink reflex modification by a prepulse (i.e. PPI) reflects the intrinsic characteristics of the 
reflex circuit rather than an external adjustment of the reflex by the prepulse. The excitability 
of blink reflex circuits can be estimated using another form of startle modification, the so-
called paired pulse suppression (PPSI) of the startle paradigm, in which pairs of identical 
blink-eliciting stimuli, separated typically by 500 to 2000 ms, are presented. The ratio of the 
response magnitude to the second stimulus (S2) relative to the first stimulus (S1) serves as a 
measure of the blink reflex circuit excitability (Kimura 1983; Powers et al. 1997). Normally, 
upon perception of the startle-eliciting stimulus excitatory processes initially dominate the 
reflex circuit, whereas inhibitory processes are prominent at a later phase. The inhibitory 
period initiated by S1 dominates usually for several hundreds of milliseconds, thus with lead 
intervals of less than 1500 ms, the blink evoked by S2 is smaller than that elicited by S1 
                                                 
I Also often denoted as “paired pulse inhibition”. The term “paired pulse suppression” has been preferred in the 
present report as “paired pulse inhibition” and “prepulse inhibition” would share the same abbreviation. 
 
(Kimura 1973; Powers et al. 1997). With each eyelid movement due to a blink, air races 
through the eyelashes and the lid rubs against the cornea. Presentation of either of these 
stimuli is sufficient to elicit a reflex blink. Thus, if a blink or the stimulus that evokes it fails 
to initiate such a period of inhibition, then each blink will elicit a reflex blink, starting 
blepharoclonus or a spasm of lid closure (Powers et al. 1997). The state of the blink reflex 
circuit is labelled as hyper-excitable, if the subject’s response to S2 is even greater than the 
response magnitude elicited by S1. Abnormalities in blink reflex excitability has been 
observed in various neurological and psychiatric disorders like Parkinson’s disease (Kimura 
1973; Schicatano et al. 2000), facial palsy (Toda et al. 2005), blepharsospasm (Grandas et al. 
1998; Katayama et al. 1996), Tourette’s syndrome (Castellanos et al. 1996; Smith and Lees 
1989; Swerdlow et al. 2001b) and Huntington's disease (Agostino et al. 1988; Valls-Sole et al. 
2004). 
 
Despite a number of operational and parametric differences between PPI and PPS, 
such as the low intensity prepulse in PPI compared to the distinct startle evoking stimuli used 
in PPS, and the much shorter lasting inhibitory phase initiated by the prepulse in PPI (<500 
ms) compared to the long lasting inhibitory period elicited by S1 in PPS (>1000 ms), there are 
also many similarities: Both PPI and PPS can be demonstrated across species using 
comparable stimulus parameters (Schicatano et al. 2000; Swerdlow et al. 2002), and both are 
disrupted by the dopamine agonist apomorphine in rodents (Swerdlow et al. 2002). Moreover, 
PPI and PPS are known to be deficient in patients with Tourette’s syndrome (Castellanos et 
al. 1996; Smith and Lees 1989; Swerdlow et al. 2001b) and blepharospasm (Grandas et al. 
1998; Katayama et al. 1996), and it has been shown that the two phenomena are highly 
correlated in humans as well as in rodents (Schicatano et al. 2000; Swerdlow et al. 2002). 
However, it is noteworthy that most of the experiments investigating deficient inhibitory 
processes in various patients populations rarely make use of both PPI and PPS within the 
same study. For instance neurological disorders like Parkinson’s disease and blepharospasm 
have been intensively investigated using PPS, while psychiatric disorders like schizophrenia 
have been characterised by the use of PPI. It is of great importance to understand the 
conceptual difference underlying these two paradigms of startle modification: while deficits 
characterised on the basis of PPS are discussed in relation to blink circuit excitability, results 
derived from PPI experiments are discussed in terms of sensorimotor gating. This has led 
Swerdlow and coworkers (Swerdlow et al. 2002) to conclude that clinical research using PPI 
and PPS have run strikingly parallel, nonintersecting paths. 
 
 The primary aim of the present study was to investigate the two conceptual divergent 
approaches underlying the regulation of PPI. Namely if deficient sensorimotor gating in 
schizophrenia patients is related to weakened reaction to or detection of the prepulse stimulus 
or alternatively, if deficient PPI is associated with the excitatory state of the blink reflex 
circuit and therefore regulated by intrinsic characteristics of the reflex circuit. To this end, 
sensorimotor gating as indexed by PPI, the reactivity to the prepulse-alone stimulus as 
indexed by PPER and acoustic blink reflex excitability in terms of PPS were assessed within a 
single recording session in unmedicated and medicated schizophrenia patients in comparison 
to healthy control subjects. We hypothesize that PPI would be impaired in unmedicated 
schizophrenia patients, but such impairments might be limited or absent in the patients treated 
with atypical antipsychotic medication. Furthermore, we speculate that if PPI is at least partly 
regulated by the degree of the perception or detection of the prepulse stimulus, PPER would 
be reduced in patients exhibiting deficient PPI. On the other hand, if PPI is mainly determined 
by intrinsic characteristics of the blink reflex circuit, diminished PPI in the patients would be 
associated with abnormalities in PPS. 
 
 
METHODS AND MATERIALS 
Subjects 
Thirty-nine patients suffering from schizophrenia according to DSM-IV diagnostic 
criteria and 46 healthy control subjects participated in the study. 14 patients were never-
medicated, first break schizophrenia patients. Of the 25 medicated patients (all were treated 
with atypical antipsychotic medication, see Table 1), 11 had their first psychotic episode 
within the last four weeks before the time of testing. All patients were in-patients, except 5 
medicated patients who were stable outpatients. Patients were recruited through the 
Psychiatric University Hospital Zurich and the Psychiatric Services of Aargau Canton. The 
control subjects were recruited through local advertisements. The exclusion criteria in 
schizophrenia patients and controls subjects included substance dependence, major medical or 
neurological disorder, mental retardation, and hearing defects as determined by a standard 
computerized whispered voice test (for a review see Pirozzo et al. 2003). Furthermore, 
patients were excluded for evidence of any additional psychiatric illnesses other than 
 
schizophrenia. In addition, the control group was also screened by the DIA-X diagnostic 
expert system (Wittchen and Pfister 1997) to exclude those subjects with personal or family 
(first-degree relatives) histories of major psychiatric disorders. The data of three control 
subjects and two patients (one medicated, one unmedicated) were rejected because no distinct 
startle reaction could be elicited (non-responders, mean startle amplitude on pulse (S1) trials 
<10 μV). 
 
After receiving a complete description of the study (orally and written), subjects gave 
written informed consent to participate in the study. The study protocol and consent forms 
were approved by the Ethical Committee of the Zurich and Aargau cantons. On the day of 
testing, patients’ symptoms were rated with the Positive and Negative Syndrome Scale 
(PANSS) (Kay et al. 1987). Duration of illness was determined based on the first appearance 
of psychotic symptoms as reported in the case records (Kendler et al. 1987; Kumari et al. 
2000). All participants were instructed to abstain from drinking alcohol for at least 24 hours 
before each test session, not to drink any caffeine-containing beverages on the day of testing, 
and to keep their usual smoking habits. Smoking was not allowed from one hour prior to the 
recording session. In a subgroup of patients receiving low dose of sedative medication 
(lorazepam) before sleeping, the medication was not administered from the evening before 
data assessment. Demographic and clinical relevant characteristics are summarized in Table 1. 
 
 
 
 
 
 
 
Session Definition 
The test session was composed of a mixture of the following types of trials which 
were presented against a constant 70 dBA background noise: a) trials in which two startle-
eliciting stimuli (S1 and S2), separated by a stimulus onset asynchrony (SOA) of either 500 
ms (pulse-pulseSOA500ms) or 1000 ms (pulse-pulseSOA1000ms), b) trials in which a prepulse 
stimulus preceded a startle-eliciting pulse stimulus with a SOA of 60 ms (prepulse-
pulseSOA60ms) or 120 ms (prepulse-pulseSOA120ms), c) trials in which only the prepulse stimulus 
was presented (prepulse-alone), and d) trials in which no discrete stimulus other than the 
constant background noise was presented (ns trials). All stimuli and background noise 
employed in the experiment consisted of broadband white noise. The stimulus intensity of S1 
and S2 in pulse-pulse trials, and of the pulse stimulus in prepulse-pulse trials was set at 115 
dBA and was of a duration of 40 ms. The intensity of the prepulse stimulus in prepulse-pulse 
and prepulse-alone trials was 86 dBA, and was of a duration of 20 ms. Rise and fall time of all 
stimuli was less than 1 ms. The SOAs of 60 ms and 120 ms had been chosen, since a majority 
of studies with schizophrenia patients show deficient PPI at these SOAs (for a review see 
Braff et al. 2001; Hamm et al. 2001). Moreover, the two SOAs produce very reliable PPI 
occurring in over 90% of normal human volunteers who exhibit a normal startle eyeblink 
response (Graham 1979). After a 3-min period of acclimatization to the background noise, 70 
discrete trials were presented according to a variable inter-trial interval with a mean of 14 s 
(ranged from 9~17 s). The first (block 1) and last block (block 3) consisted of five 
consecutive pulse-pulse trials. The middle block (block 2) consisted of 60 trials, i.e., 12 trials 
of each of the five conditions (pulse-pulseSOA500/1000ms, prepulse-pulseSOA60ms, prepulse-
pulseSOA120ms, prepulse-alone, and ns trial), presented in a pseudo-randomised order. The two 
different SOAs (500, 1000 ms) employed in the pulse-pulse trials alternated throughout the 
whole session. The test session lasted approximately 20 min. 
 
Apparatus, Data Recording and Data Processing 
Acoustic startle stimuli were generated by EMG-SR (San Diego Instruments, San 
Diego, CA, USA) and presented binaurally through headphones (TDH-39-P, Maico, 
Minneapolis, MN, USA). The orbicularis oculi EMG was measured using the ActiveTwo 
system (Biosemi, The Netherlands). All electrodes were active silver/silver-chloride 
electrodes. Two electrodes were placed below the right eye over the orbicularis oculi muscle 
to measure eye-blink activity. The system recorded continuously during the whole session, 
 
using a sampling rate of 4096 Hz. Analyzer (Brainvision, Germany) was used to pre-process 
the recorded data. The two electrodes located over the orbicularis oculi muscle were 
referenced bipolarly, then the data band-pass filtered (30–500 Hz), down-sampled to 1000 Hz 
and rectified. Segmentation was performed from 50 ms prior to the onset of the relevant 
stimulus (the prepulse in prepulse-pulse trials, S1 in pulse-pulse and the prepulse in prepulse-
alone trials) to 1450 ms after stimulus onset. The segmented data were exported for 
quantitative analysis. The EMG record of each and every trial was separately scored using the 
WindowsTM based software emgBLINK version 1.2 (CST, Switzerland). Before scoring, the 
EMG was smoothed with a time constant of 5 ms. Baseline amplitude was calculated by the 
mean response amplitude of the first 50 ms before any stimulus onset. Stimulus response 
amplitudes were assessed as peak response minus baseline value of the respective trial. Peak 
response was defined as the highest reaction in the time-window between stimulus onset to 
150 ms after stimulus onset. Response amplitudes on ns trials were scored as peak response 
sample between 51 and 201 ms minus baseline value of the respective trial. Every trial was 
examined for signs of spontaneous eye-blinks in the scoring windows, and other possible 
signs of corrupted EMG signal, and if present the trial was excluded. A total of 193 trials out 
of a grand total of 5600 trials (<3.5%) were therefore excluded. Moreover, for three subjects 
(two controls and one medicated patient) peak latencies on prepulse-pulse trials were not 
included, because the very high PPI in these subjects resulted in the absence of a distinct 
startle reaction, and consequently the peak latency could not be reliably determined. In each 
of these cases, subjects exhibited more than 94% PPI. Analogously, peak latencies of three 
subjects (one control subject, two medicated patients) to S2 in pulse-pulse trials were rejected. 
 
Startle reactivity was indexed by the peak amplitude reaction of the startle reaction 
elicited by S1. For the calculation of PPI the ratio of the startle reaction elicited by S1 and the 
startle reaction amplitude elicited by the pulse in prepulse-pulse trials was calculated 
separately for both SOAs (60, 120 ms) and expressed as percent suppression (%PPI) by the 
formula: [1 – (amplitudeprepulse-pulse) / (amplitudeS1(block2))] × 100%. Similarly, percent PPS 
(%PPS) was calculated according to the formula: [1 – (amplitudeS2(block2)) / 
(amplitudeS1(block2))] × 100%, separately for each of the two pulse-pulse SOAs (500, 1000 ms). 
Percent habituation of the startle reaction was calculated according to the formula: [1 – 
(amplitudeS1(block3)) / (amplitudeS1(block1)] × 100%. 
 
 
 
Statistical Analysis 
All statistical analyses were conducted using the statistical software Statistica 7 for 
Windows (Statsoft Inc., OK, USA). Startle amplitudes were ln-transformed because of the 
highly skewed distribution and the resulting deviation from the normal distribution (pShapiro-
Wilk W <0.001 for all three groups), which was accompanied by a significant heterogeneity of 
variance between the three groups (Levene’s test for homogeneity; p<0.05). Even though 
parametric ANOVA can tolerate deviations from the normality assumption, enhanced 
compliance to it, which often also results in homogeneity of variance, improves considerably 
the power of the statistical tests (Bland and Altman 1996; Levine and Dunlap 1982). After ln-
transformation, startle amplitudes did not deviate significantly from normality (pShapiro-Wilk W 
>0.05 for all three groups) and homogeneity of variance (Levene’s test for homogeneity; 
p>0.05). Previous examination of non-transformed data further confirmed that the patterns of 
results were largely in agreement with those obtained using the ln-transformed data. The same 
ln-transformation was also applied to the prepulse-alone amplitudes. Percent calculations 
were performed on the basis of non-transformed startle data, and both the %PPI and %PPS 
data sets conformed to a normal distribution. 
 
Startle amplitudes were analysed using repeated measures analysis of variance 
(ANOVA) with blocks (1 to 3) as within-subject factor, and group (unmedicated patients vs 
medicated patients vs control subjects) as between-subject factor. A two-way ANOVA 
(stimulus condition as repeated measures and group as between-subject factor) for PPER was 
performed including the prepulse-alone and ns conditions. Startle amplitude latencies were 
similarly analysed with stimulus conditions S1, prepulse-pulseSOA60ms and prepulse-
pulseSOA120ms with respect to PPI, and with the stimulus conditions S1, S2SOA500 and S2SOA1000 
with respect to PPS, as within-subject factors and group as between-subject factor. The %PPI 
and %PPS values were subjected to a 2 × 3 (SOA × group) repeated measures ANOVA. 
Percent habituation was analyzed using one-way ANOVA. Pearson correlation was used to 
assess potential linear relationship between %PPI and PPER, and between %PPI and %PPS. 
Duration of illness was not taken into account in the final analysis, since our data did not 
reveal any significant difference between medicated first break and medicated chronic 
patients in any electrophysiological or psychometrical parameters assessed, which is in line 
with previous literature (Kumari et al. 2000). The significance level of all statistical tests was 
set at p<0.05. 
 
 
RESULTS 
Clinical and demographic characteristics 
Unmedicated patients and control subjects did not differ significantly in age or 
smoking habits. Medicated patients were slightly, but significantly older than unmedicated 
patients (pposthoc <0.05). However, as seen in Table 1, the mean age differences between these 
groups were minimal. Unmedicated and medicated patients did not differ in the symptoms 
rated by the PANSS. Moreover, there were no significant correlations between PANSS scores 
and any startle measures. 
 
Startle Reactivity and Habituation 
Analysis of the startle amplitudes elicited by S1, attained a significant group effect 
[F(2,77)=3.7, p<0.05], indicating reduced startle reaction in the medicated patients (pposthoc 
<0.01), independent of the factor blocks, as there was no group × blocks interaction. The 
unmedicated patients and control subjects did not differ from each other in their startle 
reaction (Fig. 1). The main effect of blocks was highly significant [F(2,154)=104.7, 
p<0.0001], reflecting the process of habituation. As the analysis of the startle reaction 
revealed no group × blocks interaction, it can be concluded that the habituation of the startle 
reaction across the three blocks did not differ significantly between patients and control 
subjects. This is in agreement with the absence of a significant difference in %habituation 
among the three groups (meancontrols=48.23 +/- 4.19% SE; meanunmedicated=52.85 +/- 9.03% SE; 
meanmedicated=49.25 +/- 5.78% SE) 
 
 
 
Figure 1. Startle reactivity (ln-transformed) of the control subjects, medicated and unmedicated schizophrenia 
patients across the three blocks of the test session. ‘*’ indicates significant (p<0.05) reduction in startle reactivity 
compared to the control subjects and unmedicated patients. Error bars refer to ± SEM. 
 
 
Prepulse Inhibition (PPI) 
Analysis of %PPI revealed a significant main effect of SOA [F(1,77)=7.45, p<0.01] 
and a significant SOA × group interaction [F(2,77)=3.2, p<0.05]. Post hoc analysis showed 
that unmedicated patients exhibited significantly reduced %PPI in the SOA60ms condition 
[p<0.05] compared to the control subjects. Medicated patients exhibited an intermediate level 
of PPI in the SOA60ms condition, between that of unmedicated patients and control subjects, 
but not significantly different from either group. %PPI at the SOA120ms condition did not 
differ among the three groups (Fig. 2). 
 
 
 
Figure 2. Percent prepulse inhibition at the two prepulse–pulse conditions (SOA: 60, 120 ms) in the control 
subjects, medicated and unmedicated schizophrenia patients. ‘*’ indicates significant (p<0.01) difference in 
%PPI compared to the control subjects. Error bars refer to ± SEM. 
 
Peak latency 
Analysis of peak latency revealed a significant effect of group [F(2,77)=3.14, p<0.05] 
and of stimulus condition [F(2,144)=29.18, p<0.0001], but not of their interaction 
[F(4,144)=1.21, p=0.31]. To test whether peak latency facilitation (i.e. the reduction of peak 
latency caused by the prepulse stimulus) differed between the three groups, post hoc pair-wise 
comparisons were performed. This analysis revealed that S1 peak latencies did not differ 
across the three groups. However, while there was significant peak latency facilitation in 
regard to the prepulse-pulseSOA60 condition across all the groups [p<0.01, for all groups], only 
the control subjects exhibited the peak latency facilitation in the prepulse-pulseSOA120 
condition [p<0.01] (Fig. 3). In contrast to these results associated with PPI, neither significant 
main effects nor an interaction between the factors SOA and group was observed in regard to 
PPS. 
 
 
 
Figure 3. Peak latencies at the S1 (pulse) condition and the two prepulse–pulse conditions (SOA: 60, 120 ms) in 
the control subjects, medicated and unmedicated schizophrenia patients. ‘*’ indicates significant (p<0.01) 
latency reduction in respect to the S1 condition. Error bars refer to ± SEM. 
 
Prepulse-elicited reactivity (PPER) 
Results of the ANOVA revealed significant main effects group [F(2,77)=5.53, p<0.01] 
and of stimulus condition [F(1,77)=8.7, p<0.01] and a non-significant group × stimulus 
condition interaction [F(2,77)=2.00, p=0.14). Nevertheless, based on our a priori hypothesis 
that the level of PPER differed in schizophrenia patients exhibiting deficient PPI in 
comparison to the healthy volunteers, post hoc pair-wise comparisons were performed. This 
analysis revealed that the control subjects and medicated patients exhibited distinct PPER 
significantly above the baseline reactivity obtained in the ns trials. Interestingly, this was not 
the case for the unmedicated patients, whose reactivity to the prepulse stimulus was not 
statistically distinguishable from that obtained in the ns trials (Fig. 4). Reactivity on ns trials 
did not differ between unmedicated patients and control subjects, but medicated patients had a 
significantly reduced baseline activity compared to control subjects (pposthoc<0.01). Pearson 
correlation analysis revealed a significant negative correlation between PPER and %PPI in the 
 
SOA60ms condition in the control subjects (R=-0.45, p<0.01) and in the unmedicated patients 
(R=-0.64, p<0.05). There was no significant correlation between PPER and %PPI in the 
SOA120ms condition for any of the three groups. 
 
 
Figure 4. Prepulse elicited reactivity (ln-transformed) at the no stimulus (NS) and prepulse-alone (PP) 
conditions in the control subjects, medicated and unmedicated schizophrenia patients. ‘*’ indicates significant 
prepulse-elicited reaction above baseline (NS). Error bars refer to ± SEM. 
 
 
Paired Pulse Suppression (PPS) 
Analysis of %PPS revealed neither a significant effect of group nor an interaction 
between SOA and group. %PPS was higher in the SOA500ms condition (meancontrols=72.29 +/- 
2.07% SE; meanunmedicated=66.75 +/- 6.93% SE; meanmedicated=74.39 +/- 3.91% SE) than in the 
SOA1000ms condition (meancontrols=46.35 +/- 3.68% SE; meanunmedicated=47.61 +/- 8.07% SE; 
meanmedicated=57.57 +/- 4.62% SE) [main effect of SOA: F(1,77)=63.28, p<0.0001]. As shown 
in Table 2, %PPS in the SOA500ms condition correlated positively with %PPI in SOA60ms 
condition in all three groups. A similar positive correlation was also found between %PPS in 
the SOA1000ms and %PPI in SOA60ms condition, but this correlation was only significant in the 
 
medicated patients, while only a trend in the same direction was observed in the unmedicated 
patients and control subjects. There were no significant correlations between any of the two 
%PPS conditions and %PPI in the SOA60ms condition among the medicated patients. In 
contrast, %PPS in SOA500ms condition correlated positively with %PPI in SOA120ms condition 
in both the unmedicated patients and control subjects (Tab. 2). Hyper-excitability was 
observed only in two cases; one unmedicated patient and one control subject exhibited 
negative %PPS values which were limited to the SOA1000ms condition. 
 
 
 
 
DISCUSSION 
To our knowledge, this is the first study assessing sensorimotor gating as indexed by 
PPI, reflex excitability in terms of PPS and the direct reaction to the prepulse stimulus (PPER) 
within a single recording session in schizophrenia patients in comparison to healthy control 
subjects. This therefore allowed us to investigate possible relationships between PPI, PPER 
and PPS, and to address specifically if deficient sensorimotor gating in schizophrenia patients 
is linked to weakened PPES or alternatively related to reflex excitability. 
 
The unmedicated schizophrenia patients exhibited deficient %PPI at the SOA60ms 
condition relative to the healthy control subjects. There was no difference in sensorimotor 
 
gating at the lead interval of 120 ms between patients and control subjects. This result is in 
line with the findings of several recent studies reporting a selective PPI impairment at shorter 
lead intervals (30 or 60 ms) but not at the 120 ms lead condition in schizophrenia patients 
(Cadenhead et al. 2000; Kumari et al. 1999, 2000, 2002; Leumann et al. 2002; Ludewig et al. 
2002, 2003; Ludewig and Vollenweider 2002; Swerdlow et al. 2006a; Wynn et al. 2004). This 
adds evidence that short lead intervals might be more sensitive for the detection of deficient 
sensorimotor gating in schizophrenia patients. In this regard, it is worth noting that PPI is 
sensitive to attentional modulation for lead intervals above 100 ms, whereas there is no 
evidence for such a modulation at shorter SOAs (Elden and Flaten 2003; Filion and Poje 
2003; Hazlett et al. 2003; Heekeren et al. 2004). Although, PPI deficits at the 120 ms lead 
interval in schizophrenia patients relative to healthy control subjects have been reported 
previously (Braff et al. 2005; Mackeprang et al. 2002; Oranje et al. 2002; Parwani et al. 2000; 
Quednow et al. 2006; Weike et al. 2000), the present result underlines the importance of 
including short SOA conditions in PPI experiments to enhance the likelihood for the detection 
of potential sensorimotor gating deficits in schizophrenia spectrum patients. 
 
Here, the medicated patients showed only a non-significant deficiency in sensorimotor 
gating, but with increased statistical power (e.g. larger sample size), a significant PPI deficit is 
likely to emerge at the SOA60ms condition. Our finding that patients receiving atypical 
antipsychotics treatment exhibited no statistically significant PPI deficit is in line with the 
results of previous studies (Kumari et al. 1999, 2000, 2002; Leumann et al. 2002; Oranje et al. 
2002; Quednow et al. 2006; Swerdlow et al. 2006a). In this connection, it is worth noting that 
the atypical antipsychotics clozapine (Vollenweider et al. 2006) and quetiapine (Swerdlow et 
al. 2006c), but not the typical antipsychotic haloperidol (Csomor et al. 2007), have been 
shown to enhance PPI in healthy volunteers with low baseline levels of sensorimotor gating. 
Despite the fact that several other studies have failed to show such PPI-elevating effects of 
atypical antipsychotics in medicated patients (Duncan et al. 2003, 2003b; Mackeprang et al. 
2002; Perry et al. 2002), the present results lend support to the suggestion that atypical 
antipsychotics have some PPI enhancing properties in schizophrenia patients. 
 
Although the unmedicated patients exhibited deficient PPI in the 60 ms lead interval 
condition, they showed a significant peak latency facilitation effect similar to that seen in the 
control subjects. This finding is in line with the results of several studies showing impaired 
PPI, as indexed by deficient amplitude suppression of the startle reflex caused by a prepulse 
 
stimulus, in the absence of deficient latency facilitation (Braff et al. 1992, 1999, 2005; 
Ludewig et al. 2003; Mackeprang et al. 2002; Meincke et al. 2004; Parwani et al. 2000). 
Moreover, while PPI at the SOA120ms condition was not reduced in any of the two patient 
groups, both unmedicated and medicated patients did not, in contrast to the control subjects, 
exhibit significant latency facilitation. Therefore, it can be concluded that deficient PPI with 
respect to startle amplitude suppression and reduced latency facilitation are not directly 
associated in schizophrenia patients. 
 
Medicated patients exhibited diminished startle reactivity in the present study. 
Although the majority of previous studies investigating sensorimotor gating have not found a 
difference in startle reactivity in medicated (Braff et al. 2005; Cadenhead et al. 2000; Duncan 
et al. 2003a; Kumari et al. 2000, 2002; Ludewig et al. 2002; Ludewig and Vollenweider 2002; 
Mackeprang et al. 2002; Oranje et al. 2002; Weike et al. 2000) or unmedicated (Duncan et al. 
2003b; Mackeprang et al. 2002; Weike et al. 2000) schizophrenia patients in comparison to 
the healthy control subjects, some studies reported an enhancement (Minassian et al. 2007; 
Parwani et al. 2000) or a reduction (Leumann et al. 2002; Meincke et al. 2004; Quednow et al. 
2006) of startle reactivity in patients predominantly receiving atypical medication. In this 
context, it has been demonstrated that atypical antipsychotics significantly reduces startle 
reactivity in healthy volunteers (Graham et al. 2001, 2004; Vollenweider et al. 2006) and 
rodents (Depoortere et al. 1997; Ouagazzal et al. 2001; Swerdlow and Geyer 1993). 
Importantly, the quantification of PPI offers a special challenge, if groups differ in their 
baseline startle reactivity (Braff et al. 2001; Swerdlow et al. 2001a). To address this in the 
present study, an additional examination utilizing analysis of covariate (ANCOVA) using 
startle amplitude as a covariate to compare %PPI in the 60 ms lead interval condition between 
three groups has been conducted. This analysis yield no fundamental different results; 
medicated patients exhibited still an intermediate level of PPI between that of unmedicated 
patients and control subjects, not significantly different from the two latter groups. However, 
it has to be noted that the use of ANCOVA is not unproblematic when the groups under 
investigation differ significantly in the covariate (Jamieson 1999; Miller and Chapman 2001; 
Owen and Froman 1998; Van Breukelen 2006; Wainer 1991). 
 
Unlike the control subjects and medicated patients, the unmedicated patients failed to 
show any detectable reaction to the prepulse stimulus, i.e., their PPER was statistically 
indistinguishable from their baseline reactivity recorded in ns trials. This finding of deficient 
 
PPER cannot be attributed to a general reduction in sensitivity to acoustic stimulation, since 
unmedicated patients and control subjects did not differ in their startle reactivity. The finding 
that healthy control subjects and medicated schizophrenia patients exhibited significant 
PPER, while unmedicated patients did not, seems to be at odds with that of Swerdlow et al. 
(2006b), who could neither find PPER in healthy volunteers nor in schizophrenia patients 
using a wide range of prepulse stimulus intensities. Nevertheless, these authors reported a 
trend for reduced PPER in patients relative to the control subjects at the prepulse intensity of 
86 dB (16 dB above background noise). However, since Swerdlow and colleagues (2006b) 
did not employ prepulse-pulse trials in their test session, they were not able to measure PPI at 
the same time and therefore preventing a direct evaluation of any possible relationship 
between PPI and PPER. In contrast, the present study is the first to investigate PPER and PPI 
in schizophrenia patients, with and without antipsychotic treatment. 
 
The pattern of %PPI at the SOA60ms condition indicates deficient sensorimotor gating 
in the unmedicated patients, whereas medicated patients exhibited PPI levels in-between that 
of unmedicated patients and the control subjects. Interestingly, a parallel pattern of outcome 
was observed with respect to PPER. The combination of deficient PPI and the absence of 
PPER in the unmedicated patients is consistent with the hypothesis that impaired 
sensorimotor gating in schizophrenia patients is related to weakened detection of the prepulse 
stimulus. However, this view is inconsistent with the negative correlation between PPI and 
PPER. Similarly, Dahmen & Corr (2004) found a negative correlation between the response 
probability to prepulse stimuli, ranging from 80 to 90 dBA (in the presence of 70 dBA 
background noise), and PPI for some but not all prepulse conditions. Indeed, the relationship 
between PPI and PPER seems to underlie a complex pattern, especially in the light of the fact 
that Yee and coworkers (2004b, 2004a) found an opposite (positive) correlation between PPI 
and PPER in mice. A positive correlation between the two measures would be in accordance 
with the theoretical accounts on sensorimotor gating formulated by Graham (1975, 1980, 
1992). Moreover, it would fit the observations of PPI enhancement by directing the subjects’ 
attention towards the prepulse stimulus (Elden and Flaten 2003; Filion and Poje 2003; Hazlett 
et al. 2003; Heekeren et al. 2004), and the disruption of PPI by the dopamine agonist 
apomorphine in rats might be attributed to a reduced detectability of prepulse stimuli (Davis 
et al. 1990), although Yee et al. (2004b) found that apomorphine enhanced PPER while 
disrupted PPI in rodents. However, it is known that PPER directly detectable by the means of 
EMG recording is not a prerequisite for the detection of PPI (Csomor et al. 2006; Swerdlow et 
 
al. 2004; Yee and Feldon 2005). Nevertheless, unmedicated patients, exhibiting a deficiency 
in PPI could be distinguished from the medicated patients and control subjects in terms of 
PPER. The degree to which PPER is causally linked to the expression of sensorimotor gating 
in the form of PPI has to be further investigated in humans, including patients, and animals in 
conjunction with specific pharmacological challenge. 
 
The present study is also the first to compare PPS and PPI within a single test session 
in schizophrenia patients and healthy controls. Although, %PPS and %PPI were positively 
correlated, at least for some lead interval conditions, %PPS was, unlike %PPI, not deficient in 
either unmedicated or medicated schizophrenia patients. The correlation between the two 
measures is in agreement with the findings in humans and rodents (Schicatano et al. 2000; 
Swerdlow et al. 2002). Hyper-excitability was not a prominent characteristic of the blink 
reflex circuit in the schizophrenia patients, since only one patient (and one control subject) 
exhibited negative %PPS values. The present data do not support the view that deficient PPI 
in schizophrenia is due to enhanced or abnormal blink reflex excitability. In contrast, it has 
been proposed by Schicatano et al. (2000) that the reflex modification by a prepulse (i.e. PPI) 
reflects the intrinsic characteristics of the reflex circuit rather than an external adjustment of 
the reflex by the prepulse. If this would have been the case parallel deficient PPS in 
unmedicated patients would have emerged. Similarly, it has been shown that impaired PPI in 
patients with Parkinson’s and Huntington’s disease did not depend on blink reflex excitability 
(Valls-Sole et al. 2004). 
 
The degree to which PPI and PPS may reflect similar or different (independent) brain 
processes is currently not well understood. Given that the main difference between the two 
paradigms lies mainly in the intensity of the prestimulus, it is highly unlikely that the concepts 
of sensorimotor gating with respect to PPI and reflex excitability in terms of PPS can be 
easily separated. Indeed, there is evidence that the two forms of startle modification share a 
common ground. In addition to the correlative nature between PPI and PPS, Swerdlow et al. 
(2002) demonstrated that a weak prepulse stimulus shortly preceding S1 attenuated the startle 
response elicited by S1 to a great extent without affecting PPS per se. This led the authors to 
conclude that PPS is independent of the motor response elicited by S1. However, the 
inhibitory phase initiated by intense prestimulation in PPS exceeds the inhibitory phase 
caused by a much weaker prepulse in PPI by more than 1000 ms, thus reflecting an apparent 
difference between the two paradigms. The influence of different stimulus intensities and lead 
 
intervals has been studied extensively in humans and animals. It is widely accepted that a 
more intense prepulse will generate a stronger PPI effect (Blumenthal 1995; Graham and 
Murray 1977b), and that PPI decreases with increasing lead intervals beyond 100-150 ms, 
resulting in an absence or even facilitation at very long SOAs (i.e. 2000 ms) (Aubert et al. 
2006; Plappert et al. 2004). Consequently, with sufficiently high prepulse stimulus intensities 
appreciable levels of PPI can be measured even at long SOAs, at which minimal inhibition or 
facilitation would normally be observed with low prestimulus intensities (Plappert et al. 
2004). From this point of view it can be concluded that PPS and PPI indeed engage, at least to 
a great extent, the same neural mechanisms, and thus to completely separate the concepts of 
PPS (reflex circuit excitability) and PPI (sensorimotor gating) may not be sustainable. 
However, the extent to which this conclusion can be generalized needs to be further tested 
using auditory stimulation for both PPI and PPS, since most existing data from PPS 
experiments are based on trigmenial rather than auditory evoked blink reflexes. Nevertheless, 
the present results add further evidence to the conclusion by Powers and coworkers (1997) 
that low intensity prepulses as used in PPI and blink-evoking “prepulses” as used in PPS 
might be two ends of a continuum. 
 
Conclusion: 
Our results showed that diminished PPI was accompanied by reduced PPER in 
unmedicated schizophrenia patients. The unmedicated patients could therefore be 
distinguished from the medicated patients and control subjects in terms of PPER. These 
findings would support that reduced sensorimotor gating in schizophrenia patients might be 
linked to a reduced perception and / or processing of the prepulse stimulus. In contrast, 
although in some conditions correlated with PPI, PPS was neither reduced compared to the 
control subjects nor were the patients’ reflex circuit state hyper-excitable. To what degree 
PPER is associated with sensorimotor gating has to be further investigated in human and 
animal studies, including patient studies covering a wide range of psychiatric and 
neurological diseases and by the use of pharmacological manipulation in healthy volunteers 
and animals. 
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